SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zandu Realty Ltd. - (Amalgamated) (ZANDUREALT)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506720 NSE: ZANDUREALT Pharmaceuticals & Drugs | Small Cap | Zandu Realty-(Amalga Share Price

BSE Share Price
Not Listed

Zandu Realty Ltd. - (Amalgamated) (ZANDUREALT)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506720 NSE: ZANDUREALT Pharmaceuticals & Drugs | Small Cap | Zandu Realty-(Amalga Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹153 Cr.
Current Price
₹0
52-Week Low / High
₹1,850 / 1,951
TTM EPS
₹78.3
TTM Sales
₹0.1 Cr.
Book Value per Share
₹2,303.5
P/E Ratio
24.21
Industry PE
48.5
Price to Book (P/B)
0.82
Price to Sales (P/S)
1592.60
EV/EBITDA
14.10
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
2.80%
Return on Capital Employed (ROCE)
4.17%
Return on Assets (ROA)
2.55%
Operating Profit Margin
-72.6%
Net Profit Margin
100.98%
Gross Profit Margin
127.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-40.83%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-26.52%
Asset Quality
Promoter Holding
35.51%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹178 Cr.
Equity
₹8.1 Cr.
Face Value
₹100
All Time Low / High
₹650.00 / 24643.20

Zandu Realty . - (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
ROCE % 33.7%42.4%5.6%3.3%-138%2.9%54.2%52%5.7%4.2%-

Growth Parameters

Sales 13687.3007002986.98.75.10
Sales YoY Gr.--35.9%-100%NANA-100%NA199.3%-90%-40.8%-
Adj EPS 196.417116.411.3-871.616.7476.6797.187.464.278.3
YoY Gr.--12.9%-90.4%-30.6%-7785.6%NA2750.4%67.2%-89%-26.5%-
BVPS (₹) 962.9285.4302.6314887903.71,380.32,177.32,264.82,3292,303.5
Adj Net
Profit
15.813.81.30.9-70.31.438.464.37.15.26
Cash Flow from Ops. 22.813.50-1.472.2-565.67-36-
Debt/CF from Ops. 0000000501.9-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales -30.5%-40.7%-43.9%-40.8%
Adj EPS -11.7%NA-48.7%-26.5%
BVPS10.3%21.3%19.1%2.8%
Share Price - - - -

Key Financial Parameters

Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
21.727.45.60.6-29.90.718.631.43.62.63.4
Op. Profit
Mgn %
17.120.800-102.1077.3-3.5-39.2-72.6-1607.6
Net Profit
Mgn %
11.615.800-100.40132.37481.31016312.6
Debt to
Equity
00000000.200.1-
Working Cap
Days
8673001,25501,5744923,1822,9989,338
Cash Conv.
Cycle
940094101,3692818929698,685

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Sales136.2487.290070029.0486.918.675.13
Operating Expenses + 113.0970.330.840.64141.433.576.5989.9312.078.85
Manufacturing Costs26.4517.300.140.080.010.020.190.140.040.04
Material Costs37.2021.2000139.412.564.7882.567.554.23
Employee Cost 13.658.56000000.050.300.31
Other Costs 35.7723.270.710.552.020.991.627.184.174.28
Operating Profit 23.1516.96-0.84-0.64-71.43-3.5722.45-3.02-3.40-3.72
Operating Profit Margin (%) 17.0%19.4%---102.0%-77.3%-3.5%-39.2%-72.6%
Other Income + 4.175.842.161.454.615.6827.4486.7614.5411.68
Exceptional Items 0000000000
Interest 0.400.2400000.342.162.321.42
Depreciation 2.621.4500000000
Profit Before Tax 24.3121.111.320.81-66.822.1249.5581.588.826.54
Tax 7.905.86-0.07-0.103.460.7711.1217.301.771.36
Profit After Tax 16.4115.251.390.91-70.281.3538.4364.277.055.18
PAT Margin (%) 12.0%17.5%---100.0%-132.3%74.0%81.3%101.0%
Adjusted EPS (₹)203.5189.217.311.3-871.016.7476.6797.187.464.2
Dividend Payout Ratio (%)36.90%0%0%0%0%0%0%0%0%0%

Valuation of Zandu Realty-(Amalga - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund + 77.6523.0124.40270.30200.01201.36213.05196.75196.43197.49
Share Capital 8.068.068.068.068.068.068.068.068.068.06
Reserves 69.5814.9516.34262.23191.95193.30204.99188.69188.37189.42
Debt +0.1600000035011.40
Long Term Debt0.16000000000
Short Term Debt000000035011.40
Minority Interest0000000000
Trade Payables11.280.010.640.03000000
Others Liabilities 16.121.0517.099.803.740.7156.030.591.020.44
Total Liabilities 105.2024.0742.13280.13203.76202.07269.09232.34197.46209.33

Fixed Assets

Net Fixed Assets +180.026.020000000
Gross Block68.720.266.260000000
Accumulated Depreciation50.720.240.240000000
CWIP 26.19000000000
Investments 12.0322.491.460.010.0191.51125.21135.21140.09182.37
Inventories16.0500251111.59109.03104.2521.6914.149.92
Trade Receivables3.36000004.573.363.150
Cash Equivalents 12.540.651.102.010.670.563.443.360.040.06
Others Assets 17.030.9233.5627.1191.480.9731.6268.7340.0416.98
Total Assets 105.2024.0742.13280.13203.76202.07269.09232.34197.46209.33

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity + 22.8313.520.04-1.3672.22-5.0165.627.01-3.025.95
PBT 24.3121.111.320.81-66.822.1249.5581.588.826.54
Adjustment -0.583.08-1.87-1.45-4.56-5.36-26.53-84.88-12.50-9.92
Changes in Working Capital 6.74-2.770.63-1.67144.62.3543.5439.532.4310.69
Tax Paid -7.65-7.90-0.040.95-1-4.11-0.94-29.22-1.77-1.36
Cash Flow From Investing Activity + -16.76-17.540.292.28-73.564.89-62.72-39.9836.60-15.98
Capex -10.03-8.33-60000000
Net Investments -4.92-8.4521.141.450-91.50-33.70-10-4.88-42.28
Others -1.80-0.76-14.850.83-73.5696.39-29.02-29.9841.4826.30
Cash Flow From Financing Activity + -5.94-2.290.12000-0.0132.88-36.9010.06
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -000000-0.01-2.12-1.90-1.34
Dividend Paid -5-1.930.120000000
Others -0.94-0.36-0000035-3511.40
Net Cash Flow 0.13-6.320.450.92-1.34-0.122.89-0.09-3.320.03

Financial Ratio

PARTICULARSMar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Ratios
ROE (%)22.4630.315.873.68-145.141.8741.7344.813.942.8
ROCE (%)33.7442.355.563.27-1382.9354.1852.035.674.17
Asset Turnover Ratio1.571.45000.2900.120.350.040.03
PAT to CFO Conversion(x)1.390.890.03-1.49N/A-3.711.710.11-0.431.15
Working Capital Days
Receivable Days8.100000057.4016.60137.100
Inventory Days40.70000945.3001,340.40264.50754.50856.40
Payable Days109.4097.2000000000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zandu Realty Ltd. - (Amalgamated) FAQs

The current trading price of Zandu Realty-(Amalga on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zandu Realty-(Amalga stood at ₹152.9 Cr

The latest P/E ratio of Zandu Realty-(Amalga as of 31-Dec-1969 is 24.21.

The latest P/B ratio of Zandu Realty-(Amalga as of 31-Dec-1969 is 0.82.

The 52-week high of Zandu Realty-(Amalga is ₹1,950.9 and the 52-week low is ₹1,850.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zandu Realty-(Amalga is ₹0.10 ( Cr.) .

Data is not available for this company.

The key valuation ratios of Zandu Realty Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Undervalued zone.

No data found

About Zandu Realty Ltd. - (Amalgamated)

Zandu Pharmaceutical works name was changed to Zandu Realty from March 10, 2010. At present, the company is a multi-product entity, comprising a group of companies. Zandu projects a sale of nearly Rs. 2,000/- Million by 2000 A.D.

It was listed in 1919; is engaged in offering ayurvedic healthcare medicines.

Zandu manufactures a wide range of ayurvedic medicine specialised in area of rheumatology, gynaecology and CNS (Central nervous system).

Using 200 medicinal plants and their extracts it manufactures 300 healthcare products. The company markets its products under the brand name Zandu.

The company exports herbal health care products to U.S.A, Europe and Asian countries.

The chemical division is located at Ankleshwar that manufactures bulk drugs and intermediates. The cosmetics division manufactures wide range of skin care products such as lotion, soaps, shampoo, creams, etc. It markets the cosmetic products under name Z-naree.

It manufactures products such as zandu balm, brento, kesari-jivan, zandu honey, triphala churna, sudarshan, rhumasyl oil, gulbahar, chandra prabhavati, etc.

ZPWL has formed joint venture with Gujarat Agro Industries Corporation to manufacture glycyrrhiza extract from a vegetable plant-extraction project.

In the year 1989 Leopard Investments Private Limited has become the subsidiary of ZPWL.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: